CAR19TIF cells: Clinical Trials

2 trials of CAR19TIF cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 22Recruiting 2

Follow CAR19TIF cells: new trials by email Literature Review of CAR19TIF cells trials Research Report on CAR19TIF cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL
CAR19TIF cells, Fludarabine, Cyclophosphamide - Acute Lymphocytic Leukemia
Phase 1 / Phase 2RecruitingChinese PLA General Hospital302025-06-202025-06-25
BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
CAR19TIF cells, Fludarabine, Cyclophosphamide - B Cell Lymphoma
Phase 1 / Phase 2RecruitingChinese PLA General Hospital302025-06-202025-06-25

Conditions studied

Lymphoma, B-Cell (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Chinese PLA General Hospital (2)

Countries

China (2)

Top investigators

Weidong Han, Ph.D (2)